Dongwha Pharm, Active Community... Stock Price -3.55%.

At this time, posts about Dongwha Pharm are rapidly increasing on portals and stock communities. Today, foreigners have tentatively purchased a net 89,264 shares of Dongwha Pharm, while institutions have sold a net 5,000 shares. Dongwha Pharm is known as a manufacturer and seller of pharmaceuticals (such as Gas Hwal Myeong Su and Fusidin).

As of 12:30 PM on the 14th, Dongwha Pharm's stock price is 21,750 KRW, down 3.55% from the previous day, with a trading volume of 1,433,192 shares, which is about 35.62% of the 5-day average trading volume. On August 12, Dongwha Pharm became a market issue with the news "DW2008 COVID-19 treatment entering Phase 2 clinical trials ↑."

In addition to Dongwha Pharm, posts by investors are also surging for Doosan Heavy Industries & Construction (034020), SK Innovation Preferred (096775), and Orient Bio (002630).

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.